Skip to main content
Top
Published in: Rheumatology International 1/2012

01-01-2012 | Original Article

Early endoscopy in systemic sclerosis without gastrointestinal symptoms

Authors: Rene Thonhofer, Cornelia Siegel, Markus Trummer, Winfried Graninger

Published in: Rheumatology International | Issue 1/2012

Login to get access

Abstract

Investigation into the upper GI-tract of patients suffering from systemic sclerosis [SSc] and mixed connective tissue disease [MCTD] without symptoms of GI-tract involvement early in the course of the disease to diagnose inflammatory and motility disorders. We retrospectively analysed patients with SSc and MCTD who underwent oesophago-gastro-duodenoscopy [OGD] within a year of the first diagnosis. Patients with a Rodnan skin score above 5, proton pump inhibitors and treatment regimes potentially harmful to the mucosa of the upper GI-tract were excluded. Mucosal damage of the oesophagus was classified according to the Los Angeles Classification. Oesophageal dysmotility was assessed during OGD and confirmed by video cineradiography. A total of thirteen patients with SSc and six with MCTD fulfilled the inclusion criteria. OGD revealed reflux-oesophagitis in 77%, dysmotility of the distal oesophagus in 85%, gastritis in 92% [31% erosive gastritis] and Helicobacter pylori positivity in 38% of our patients suffering from SSc. Patients with MCTD showed features of reflux-oesophagitis, dysmotility of the distal oesophagus, gastritis and dysmotility of the stomach in 0.6%. In all thirteen patients with SSc, significant pathology of the upper GI-tract was found. The results of this study might indicate that OGD should be performed early in patients diagnosed with SSc, even if they do not report typical symptoms. An early diagnose of GI involvement might be followed by an effective therapy and therefore subsequently may improve the prognosis.
Literature
1.
go back to reference Marie I, Ducrotte P, Denis P, Hellot MF, Levesque H (2006) Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther 24:1593–1601PubMedCrossRef Marie I, Ducrotte P, Denis P, Hellot MF, Levesque H (2006) Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther 24:1593–1601PubMedCrossRef
2.
go back to reference Weihrauch TR, Korting GW, Ewe K, Vogt G (1978) Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis. Klin Wochenschr 56:963–968PubMedCrossRef Weihrauch TR, Korting GW, Ewe K, Vogt G (1978) Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis. Klin Wochenschr 56:963–968PubMedCrossRef
3.
go back to reference Weston S, Thumshirn M, Wiste J, Camilleri M (1998) Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 93:1085–1089PubMedCrossRef Weston S, Thumshirn M, Wiste J, Camilleri M (1998) Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 93:1085–1089PubMedCrossRef
4.
go back to reference Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA (2006) Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum 36:173–181PubMedCrossRef Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA (2006) Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum 36:173–181PubMedCrossRef
5.
go back to reference Yarze JC, Varga J, Stampfl D, Castell DO, Jimenez SA (1993) Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 88:870–876PubMed Yarze JC, Varga J, Stampfl D, Castell DO, Jimenez SA (1993) Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 88:870–876PubMed
6.
go back to reference Yamamoto M, Takahashi H, Akaike J, Suzuki C, Naishiro Y, Yamamoto H et al (2008) Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis. Scand J Rheumatol 37:315–316PubMedCrossRef Yamamoto M, Takahashi H, Akaike J, Suzuki C, Naishiro Y, Yamamoto H et al (2008) Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis. Scand J Rheumatol 37:315–316PubMedCrossRef
7.
go back to reference Marie I, Levesque H, Ducrotté P, Denis P, Hellot MF, Benichou J et al (2001) Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol 96:77–83PubMedCrossRef Marie I, Levesque H, Ducrotté P, Denis P, Hellot MF, Benichou J et al (2001) Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol 96:77–83PubMedCrossRef
8.
go back to reference Nishimagi E, Tochimoto A, Kawaguchi Y, Satoh T, Kuwana M, Takagi K et al (2007) Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol 34:2050–2055PubMed Nishimagi E, Tochimoto A, Kawaguchi Y, Satoh T, Kuwana M, Takagi K et al (2007) Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol 34:2050–2055PubMed
9.
go back to reference Szamosi S, Szekanecz Z, Szucs G (2006) Gastrointestinal manifestations in Hungarian scleroderma patients. Rheumatol Int 26:1120–1124PubMedCrossRef Szamosi S, Szekanecz Z, Szucs G (2006) Gastrointestinal manifestations in Hungarian scleroderma patients. Rheumatol Int 26:1120–1124PubMedCrossRef
10.
go back to reference Tsianos EB, Drosos AA, Chiras CD, Moutsopoulos HM, Kitridou RC (1987) Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity? Rheumatol Int 7:23–27PubMedCrossRef Tsianos EB, Drosos AA, Chiras CD, Moutsopoulos HM, Kitridou RC (1987) Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity? Rheumatol Int 7:23–27PubMedCrossRef
11.
go back to reference Sandqvist G, Eklund M, Akesson A, Nordenskiöld U (2004) Daily activities and hand function in women with scleroderma. Scand J Rheumatol 33:102–107PubMedCrossRef Sandqvist G, Eklund M, Akesson A, Nordenskiöld U (2004) Daily activities and hand function in women with scleroderma. Scand J Rheumatol 33:102–107PubMedCrossRef
12.
go back to reference Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef
13.
go back to reference Wegener M, Adamek RJ, Wedmann B, Jergas M, Altmeyer P (1994) Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 39:2209–2215PubMedCrossRef Wegener M, Adamek RJ, Wedmann B, Jergas M, Altmeyer P (1994) Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 39:2209–2215PubMedCrossRef
14.
go back to reference Treacy WL, Baggenstoss AH, Slocumb CH, Code CF (1963) Scleroderma of the esophagus. A correlation of histologic and physiologic findings. Ann Intern Med 59:351–356PubMed Treacy WL, Baggenstoss AH, Slocumb CH, Code CF (1963) Scleroderma of the esophagus. A correlation of histologic and physiologic findings. Ann Intern Med 59:351–356PubMed
15.
go back to reference LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
16.
go back to reference LeRoy EC, Medsger TA Jr (2001) Criteria fort he Classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed LeRoy EC, Medsger TA Jr (2001) Criteria fort he Classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed
17.
go back to reference von Mühlen CA, Tan EM (1995) Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24:323–358CrossRef von Mühlen CA, Tan EM (1995) Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24:323–358CrossRef
18.
go back to reference Alarcón-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328–334PubMed Alarcón-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328–334PubMed
19.
go back to reference Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159PubMedCrossRef Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159PubMedCrossRef
20.
go back to reference Lambova SN, Müller-Ladner U (2009) The role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int 29:1263–1271PubMedCrossRef Lambova SN, Müller-Ladner U (2009) The role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int 29:1263–1271PubMedCrossRef
21.
go back to reference Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D’Angelo WA et al (1998) The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 25:84–88PubMed Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D’Angelo WA et al (1998) The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 25:84–88PubMed
22.
go back to reference Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed
23.
go back to reference Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP et al (1996) The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111:85–92PubMedCrossRef Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP et al (1996) The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111:85–92PubMedCrossRef
24.
go back to reference Mantzaris GJ, Petraki K, Archavlis E, Amberiadis P, Christoforidis P, Kourtessas D et al (2002) Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study. Eur J Gastroenterol Hepatol 14:1237–1243PubMedCrossRef Mantzaris GJ, Petraki K, Archavlis E, Amberiadis P, Christoforidis P, Kourtessas D et al (2002) Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study. Eur J Gastroenterol Hepatol 14:1237–1243PubMedCrossRef
25.
go back to reference Doria A, Bonavina L, Anselmino M, Ruffatti A, Favaretto M, Gambari P et al (1991) Esophageal involvement in mixed connective tissue disease. J Rheumatol 18:685–690PubMed Doria A, Bonavina L, Anselmino M, Ruffatti A, Favaretto M, Gambari P et al (1991) Esophageal involvement in mixed connective tissue disease. J Rheumatol 18:685–690PubMed
26.
go back to reference Franck-Larsson K, Hedenström H, Dahl R, Rönnblom A (2003) Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity. Scand J Rheumatol 32:348–355PubMedCrossRef Franck-Larsson K, Hedenström H, Dahl R, Rönnblom A (2003) Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity. Scand J Rheumatol 32:348–355PubMedCrossRef
27.
go back to reference Hendel L, Hage E, Hendel J, Stentoft P (1992) Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. Aliment Pharmacol Ther 6:565–577PubMedCrossRef Hendel L, Hage E, Hendel J, Stentoft P (1992) Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. Aliment Pharmacol Ther 6:565–577PubMedCrossRef
Metadata
Title
Early endoscopy in systemic sclerosis without gastrointestinal symptoms
Authors
Rene Thonhofer
Cornelia Siegel
Markus Trummer
Winfried Graninger
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1595-y

Other articles of this Issue 1/2012

Rheumatology International 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.